CLINICAL MICROBIOLOGY AND INFECTION

Scope & Guideline

Unveiling Insights for a Healthier Tomorrow

Introduction

Welcome to your portal for understanding CLINICAL MICROBIOLOGY AND INFECTION, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1198-743x
PublisherELSEVIER SCI LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1995 to 2024
AbbreviationCLIN MICROBIOL INFEC / Clin. Microbiol. Infect.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

The journal 'Clinical Microbiology and Infection' focuses on the multifaceted aspects of infectious diseases, emphasizing clinical, microbiological, and epidemiological research. It aims to provide a platform for disseminating knowledge that enhances the understanding of microbial infections and informs clinical practice, public health policies, and antimicrobial stewardship.
  1. Clinical Microbiology and Diagnostic Techniques:
    The journal highlights advancements in clinical microbiology, including the development and evaluation of diagnostic tests for infectious diseases, and the role of microbiological data in guiding treatment decisions.
  2. Antimicrobial Resistance and Stewardship:
    A significant focus on the mechanisms, epidemiology, and clinical implications of antimicrobial resistance, with an emphasis on strategies for effective antimicrobial stewardship in various healthcare settings.
  3. Infectious Diseases Epidemiology:
    Research on the epidemiology of infectious diseases, including surveillance studies, outbreak investigations, and the impact of public health interventions on infection control and prevention.
  4. Infection Management and Treatment Protocols:
    The journal provides insights into clinical management strategies for various infections, including novel treatment regimens, evaluation of therapeutic efficacy, and management of co-infections, especially in vulnerable populations.
  5. Emerging Infections and Public Health Responses:
    Coverage of emerging infectious diseases, including their epidemiological trends, public health responses, and the implications of global health crises like the COVID-19 pandemic.
The journal has increasingly published on several trending topics that reflect the contemporary challenges in infectious disease management and research, particularly in response to global health issues.
  1. COVID-19 and Its Consequences:
    Research on COVID-19 remains a dominant theme, covering aspects like vaccine efficacy, long-term complications, and the impact of the pandemic on healthcare systems and infection rates.
  2. Antimicrobial Resistance Mechanisms:
    There is a growing emphasis on understanding the mechanisms of antimicrobial resistance, particularly in the context of emerging resistant pathogens and their clinical implications.
  3. Microbiome Research:
    Studies exploring the human microbiome's role in health and disease are on the rise, particularly concerning its interactions with infectious agents and implications for treatment.
  4. Telemedicine and Remote Patient Management:
    The integration of telemedicine in managing infectious diseases, especially during the COVID-19 pandemic, is increasingly being explored, reflecting changes in patient care models.
  5. Global Health and Infectious Disease Preparedness:
    Emerging themes include global health initiatives, preparedness for future pandemics, and the intersection of infectious diseases with social determinants of health.

Declining or Waning

Despite its broad scope, certain themes within 'Clinical Microbiology and Infection' are witnessing a decline in publication frequency, reflecting shifts in research priorities and emerging health challenges.
  1. Traditional Laboratory Techniques:
    There appears to be a waning focus on conventional laboratory methods and techniques in microbiology, as newer, more efficient diagnostic technologies gain prominence.
  2. Basic Research on Non-Pathogenic Strains:
    Research related to benign or non-pathogenic strains of microorganisms is becoming less common, as the journal shifts towards clinically relevant pathogens and their impact on health.
  3. Historical Perspectives on Infectious Diseases:
    Studies that primarily focus on historical analyses of infectious diseases and their management are decreasing, with a stronger emphasis now on contemporary issues and real-time data.

Similar Journals

Infectious Diseases

Fostering Global Collaboration in Infectious Diseases
Publisher: TAYLOR & FRANCIS LTDISSN: 2374-4235Frequency: 12 issues/year

Infectious Diseases, published by TAYLOR & FRANCIS LTD, is a leading academic journal dedicated to advancing research in the field of infectious diseases and microbiology. With an impressive impact factor and categorized in Q1 in multiple areas including Immunology and Microbiology, this journal serves as a critical platform for researchers, practitioners, and students to disseminate their findings and stay abreast of current advancements. The journal is recognized for its rigorous peer-review process and aims to foster innovation and collaboration across disciplines from 2015 to 2024. It boasts a robust Scopus ranking, positioning it favorably among the top-tier of journals in the relevant fields, making it an essential resource for anyone involved in infectious disease research. Access options are available, ensuring that the latest research is accessible to a global audience, thus emphasizing the journal's commitment to promoting knowledge and understanding in the ever-evolving landscape of infectious diseases.

CLINICAL INFECTIOUS DISEASES

Pioneering research for a healthier tomorrow.
Publisher: OXFORD UNIV PRESS INCISSN: 1058-4838Frequency: 24 issues/year

Clinical Infectious Diseases, published by Oxford University Press Inc, is a premier journal in the fields of infectious diseases and microbiology, distinguished by its esteemed Q1 ranking in both categories as of 2023. Since its inception, the journal has served as a vital platform for disseminating cutting-edge research and significant advancements in the diagnosis, treatment, and prevention of infectious diseases. With a broad scope encompassing clinical trials, epidemiological studies, and public health research, it targets a diverse readership, including researchers, healthcare professionals, and students. The journal's robust reputation is underscored by its impactful contributions to scientific understanding, making it a critical resource for those striving to combat infectious diseases globally. Clinical Infectious Diseases is not open access but offers various subscription options, ensuring comprehensive access to its high-quality content. With a historical continuity from 1985 to present, the journal remains at the forefront of medical research, paving the way for future innovations in the field.

Infection and Chemotherapy

Fostering Dialogues for a Healthier Tomorrow
Publisher: KOREAN SOC ANTIMICROBIAL THERAPYISSN: 2093-2340Frequency: 4 issues/year

Infection and Chemotherapy, an esteemed journal published by the Korean Society of Antimicrobial Therapy, focuses on the dynamic fields of infectious diseases and pharmacology. With an ISSN of 2093-2340 and an E-ISSN of 2092-6448, this peer-reviewed, open-access journal has been providing a crucial platform for research dissemination since 2008. Based in South Korea, it boasts a significant impact in the academic community, as evidenced by its Q2 ranking in both Infectious Diseases and Pharmacology categories for 2023. It holds a Scopus rank of 64 out of 272 in Pharmacology and 98 out of 344 in Infectious Diseases, showcasing its prominence and the quality of research it publishes. With a focus on advancing scientific knowledge, Infection and Chemotherapy is committed to fostering essential dialogues among researchers, clinicians, and students, making it a vital resource for those engaged in the fight against infectious diseases and the development of effective therapeutic protocols.

Indian Journal of Medical Microbiology

Bridging Science and Clinical Practice in Microbiology
Publisher: ELSEVIERISSN: 0255-0857Frequency: 4 issues/year

Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Exploring breakthroughs in infectious disease management.
Publisher: ELSEVIER SCI LTDISSN: 1201-9712Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.

JOURNAL OF INFECTION

Advancing the Frontiers of Infectious Disease Research
Publisher: W B SAUNDERS CO LTDISSN: 0163-4453Frequency: 12 issues/year

JOURNAL OF INFECTION is a premier academic publication in the fields of infectious diseases and medical microbiology, published by W B SAUNDERS CO LTD. With a profound impact factor and established since 1979, this journal serves as a crucial resource for researchers, clinicians, and policy-makers seeking to advance knowledge and understanding of infectious processes and their management. The JOURNAL OF INFECTION holds an impressive position in the academic hierarchy as reflected by its Q1 quartile rankings in both Infectious Diseases and Microbiology (medical) for 2023, further underscored by its Scopus rankings: #2 in Medical Microbiology and #5 in Medical Infectious Diseases, placing it in the 98th percentile overall. While the journal does not offer Open Access options, it provides a comprehensive outlet for innovative research, reviews, and clinical insights that drive the field forward. Published from the United Kingdom, it attracts a global readership keen on staying at the forefront of infectious disease research, making it an essential addition to any academic and clinical library.

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA

Innovating research for a healthier tomorrow.
Publisher: AKADEMIAI KIADO ZRTISSN: 1217-8950Frequency: 4 issues/year

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA is a distinguished academic journal published by AKADEMIAI KIADO ZRT, focusing on significant advancements in the fields of microbiology, immunology, and infectious diseases. Established in 1994, this journal serves as a vital platform for researchers, professionals, and students keen on exploring the complexities of microbial interactions and immune responses. With a current Impact Factor reflecting its rank within the Q3 categories for Immunology, Microbiology, and Infectious Diseases, it retains a critical position in disseminating innovative research. Although not open access, the journal provides extensive insights disseminated through various academic databases, ensuring a broad reach within the scholarly community. Its convergence over three decades indicates a robust commitment to excellence in scientific inquiry and knowledge sharing. As it moves towards the future, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA continues to uphold its legacy of fostering collaborative research initiatives that contribute to the understanding and treatment of microbial diseases globally.

International Journal of Antimicrobial Agents

Shaping the Future of Antimicrobial Treatments
Publisher: ELSEVIERISSN: 0924-8579Frequency: 12 issues/year

International Journal of Antimicrobial Agents, published by Elsevier, stands as a premier platform in the fields of Infectious Diseases, Microbiology, and Medical Pharmacology. With an impressive impact factor and ranked in the Q1 category across multiple medical disciplines in 2023, this journal is recognized for its contribution to advancing knowledge and understanding in the efficacy and safety of antimicrobial treatments. Its comprehensive scope from 1991 to 2024 allows for the publishing of original research, reviews, and commentary on pressing issues related to antimicrobial resistance, treatment strategies, and pharmacological innovations. With a strong emphasis on high-quality research as reflected in its Scopus rankings, the journal is an essential resource for researchers, clinicians, and students dedicated to improving patient outcomes in the face of evolving microbiological challenges. Engage with the latest findings and methodologies through this vital academic resource, available in print and online, from the heart of the Netherlands.

New Microbes and New Infections

Bridging gaps in understanding novel infectious agents.
Publisher: ELSEVIER SCI LTDISSN: Frequency: 6 issues/year

New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.

Infectious Microbes & Diseases

Unraveling the complexities of microbes and their impact.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 4 issues/year

Infectious Microbes & Diseases, published by Lippincott Williams & Wilkins, is a premier journal dedicated to the exploration and understanding of infectious diseases, microbiology, and epidemiology. With its focused scope and robust peer-review process, the journal aims to disseminate high-quality research that contributes to advancements in the field, making it an essential resource for researchers, healthcare professionals, and students alike. Established in 2019, it has quickly gained recognition, achieving a Q3 rating in categories such as Epidemiology, Infectious Diseases, and Medical Microbiology in 2023, and ranking in the top half of its field within Scopus metrics. Although currently offered as a subscription-based journal, Infectious Microbes & Diseases significantly enriches its disciplines by inviting innovative research and critical review articles, thus playing a vital role in combating the global challenges posed by infectious diseases.